Bruker Adds Isis Biosensor to Research Products Portfolio, But Diagnostic Rights Appear Unlikely | GenomeWeb
Bruker Biosciences, under an alliance with Isis Pharmaceuticals announced this week, will soon begin manufacturing and selling a sophisticated biosensor system that can simultaneously identify thousands of types of infectious organisms in a single sample.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.